Marc Andreessen: Why Perfect Products Become Obsolete
The a16z Show8 Elo 2025

Marc Andreessen: Why Perfect Products Become Obsolete

In this episode, Marc Andreessen joins TBPN for an unfiltered conversation spanning everything from ads in LLMs to why Apple’s AI strategy may be risky for anyone not named Apple.

Marc breaks down the current state of AI: why open source is resurging, how foundational research is (or isn’t) turning into product, and whether we’ve hit the moment when phones start to fade as dominant platforms. He also shares his candid thoughts on Meta’s wearable wins, Vision Pro’s imperfections, and how humor and deep research are his two favorite use cases for AI today.

Timecodes:

0:00 Intro

2:41 The Pace of AI and Technology Cycles

4:03 Research vs. Productization in AI Companies

5:15 Apple’s Strategy: Last Mover Advantage

7:09 The Future Beyond Smartphones

10:23 Open Source AI: Progress and Challenges

13:49 Ads in AI: Business Models and User Experience

15:52 Legal Frameworks for AI and Data

17:53 Lightning Round: How Mark Uses AI

19:01 Breaking into Venture Capital in 2025

20:34 M&A, Survivorship Bias, and Company Resilience

Resources

Watch TBPN: https://www.tbpn.com/

Marc on X: https://x.com/pmarca

Marc’s Substack: https://pmarca.substack.com/

Stay Updated:

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1000)

On Vaccines and Vaccinology, in COVID and Beyond

On Vaccines and Vaccinology, in COVID and Beyond

WHEN are we going to have a COVID-19 vaccine, and how the heck are we going from (what’s been traditionally been up to) 12 years or so of vaccine development compressed into 12 months or so? What will...

14 Elo 202056min

Turning Open Source Developers Into Superfans

Turning Open Source Developers Into Superfans

In this episode, we continue our community series with a recent discussion that applies to many kinds of community building. Today’s topic: How do you create a platform that people not only use, but t...

10 Elo 202045min

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

CAR T therapy is a groundbreaking medicine that uses engineered T cells to attack cancer. But CAR T cells (that is, chimeric antigen receptor T cells) can be programmed to recognize a huge range of ta...

9 Elo 202018min

Working, Making, Creating in Public... and Private

Working, Making, Creating in Public... and Private

We're living in an unprecedented era of online collaboration, coordination, and creation. All kinds of people are coming together -- whether in an open source project or company, an R&D initiative, a ...

2 Elo 202047min

GPT-3: What's Hype, What's Real on the Latest in AI

GPT-3: What's Hype, What's Real on the Latest in AI

In this episode -- cross posted from our 16 Minutes show feed -- we cover all the buzz around GPT-3, the pre-trained machine learning model from OpenAI that’s optimized to do a variety of natural-lang...

30 Heinä 202033min

Taking the Pulse on Medical Device Security

Taking the Pulse on Medical Device Security

Many don’t realize we even need to think about the possibility of security hacks when it comes to things like pacemakers, insulin pumps, and more. But when bits and bytes meet flesh and blood, securit...

22 Heinä 202023min

Journal Club: A New Path to Antibiotic Resistance

Journal Club: A New Path to Antibiotic Resistance

Ever since the discovery of antibiotics, microbiologists have worried about and studied how bacteria acquire resistance to these drugs. Adding to the complexity of this problem is the fact that it is ...

19 Heinä 202017min

Cybercrime, Incorporated

Cybercrime, Incorporated

A dive into the sociological, operational, and tactical realities of this murky underworld, Lusthaus and de la Garza discuss who the players are, what they are motivated by, and specialize in—as well ...

18 Heinä 202036min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
ostan-asuntoja-podcast
rss-rahamania
herrasmieshakkerit
rss-neuvottelija-sami-miettinen
rss-h-asselmoilanen
rss-seuraava-potilas
rss-paasipodi
inderespodi
rahapuhetta
pomojen-suusta
sijoituspodi
rss-markkinointitrippi
syo-nuku-saasta
asuntoasiaa-paivakirjat
rss-laakispodi
rss-bisnesta-bebeja